Showing results (411-420 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|February 10, 2022
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based studyMichael Dörks, Falk Hoffmann, Kathrin JobskiInternational Clinical Psychopharmacology|May 7, 2019
Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled studyMojtaba Sharafkhah, Mobina Aghakarim Alamdar, Ali Massoudifar, et al.International Clinical Psychopharmacology|May 7, 2019
The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label studyDafna Sara Rubin-Kahana, Assaf Shelef, Abraham Weizman, et al.International Clinical Psychopharmacology|April 10, 2019
Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in TaiwanKuan-Pin Su, Chao-Hsiun Tang, Hui-Chih Chang, et al.International Clinical Psychopharmacology|April 19, 2019
Antipsychotics in the general population and the driver population: comparisons from a population-based registry studyFrancisco Herrera-Gómez, Eduardo Gutierrez-Abejón, F Javier ÁlvarezInternational Clinical Psychopharmacology|July 2, 2019
A personal account of depressive illness and its antidepressant treatmentDavid S BaldwinInternational Clinical Psychopharmacology|January 1, 1988
Serum and red cell folate concentrations in outpatients receiving lithium carbonateS L Stern, J T Brandt, R S Hurley, et al.International Clinical Psychopharmacology|January 1, 1988
Hematological effects of lithium potentiation of carbamazepine in patients with affective illnessR T JoffeInternational Clinical Psychopharmacology|October 23, 2021
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorderPaolo Olgiati, Alessandro SerrettiInternational Clinical Psychopharmacology|March 11, 2010
Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switchingHoward C Margolese, Yaël Wolf, Julie Eve Desmarais, et al.Pageof 212